» Husain B, Kirchberger MC, Erdmann M, Schüpferling S, Abolhassani A, Fröhlich W, Berking C, Heinzerling L (2021) Inflammatory markers in autoimmunity induced by checkpoint inhibitors. J Cancer Res Clin Oncol, April 10th
» Zlotoff DA, Hassan MZO, Zafar A, Alvi RM, Awadalla M, Mahmood SS, Zhang L, Chen CL, Ederhy S, Barac A, Banerji D, Jones-O’Connor M, Murphy SP, Armanious M, Forrestal BJ, Kirchberger MC, Coelho-Filho OR, Rizvi MA, Sahni G, Mandawat A, Tocchetti CG, Hartmann S, Gilman HK, Zatarain-Nicolás E, Mahmoudi M, Gupta D, Sullivan R, Ganatra S, Yang EH, Heinzerling LM, Thuny F, Zubiri L, Reynolds KL, Cohen JV, Lyon AR, Groarke J, Thavendiranathan P, Nohria A, Fradley MG, Neilan TG (2021) Electrocardiographic features of immune checkpoint inhibitor associated myocarditis. J Immunother Cancer, 9(3):e002007
» Kramer R, Zaremba A, Moreira A, Ugurel S, Johnson DB, Hassel JC, Salzmann M, Gesierich A, Weppler A, Spain L, Loquai C, Dudda M, Pföhler C, Hepner A, Long GV, Menzies AM, Carlino MS, Sachse MM, Lebbé C, Baroudjian B, Tomohiro Enokida T, Makoto Tahara M, Max Schlaak M, Kinan Hayani K, Bröckelmann PJ, Meier F,22, Reinhardt L, Friedlander P, Eigentler T, Kähler KC, Berking C, Zimmer L, Heinzerling L (2021) Hematological immune related adverse events after treatment with immune checkpoint inhibitors. Eur J Cancer, 147:170–181
» Krückel A, Moreira A, Fröhlich W, Schuler G, Heinzerling L (2019) Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma. BMC Cancer, 19(1):207 (Patent granted)
» Full F, van Gent M, Sparrer K, Chiang C, Zurenski M, Scherer M, Brockmeyer N, Heinzerling L, Stürzl M, Korn K, Stamminger T, Ensser A, Gack M (2019) Centrosomal protein TRIM43 restricts herpesvirus infection by regulating nuclear lamina integrity. Nature Microbiology, 4(1):164-76
» Moreira A, Groß S, Kirchberger MC, Erdmann M, Schuler G, Heinzerling L (2018) Senescence markers - predictive for response to checkpoint inhibitors? Int J Cancer, 144(5):1147-50
